Steven R Wiley

age ~61

from Seattle, WA

Get Report

Also known as:

Steven Robert Wiley
Steven Rober Wiley
Steven E Wiley
Steve R Wiley
Steve E Wiley
Steve M Wiley
Stevem Wiley
Benita Lemoine
Brandy Lemoine

Phone and address:: 3010 56Th St, Seattle, WA 98107
(206)7825442

Connected to:

Steven Wiley Phones & Addresses

3010 56Th St, Seattle, WA 98107 • (206)7825442
1511 11Th Ave W, Seattle, WA 98119 • (206)3521351
51 University St, Seattle, WA 98101
Olympia, WA
New Orleans, LA
Houston, TX
Madison, WI
Kiona, WA

Work

Company:

Imdaptive inc.
Address:

3010 Nw 56Th St, Seattle, WA 98107
Phones:

(206)7349738
Position:

Owner
Industries:

Commercial Physical and Biological Research

Ranks

Licence:

Virginia - Authorized to practice law
Date:

2001

Us Patents

Antibodies Directed Against Trail
view source
US Patent:

6521228, Feb 18, 2003
Filed:

Apr 2, 2001
Appl. No.:

09/825563
Inventors:

Steven R. Wiley - Seattle WA
Raymond G. Goodwin - Seattle WA
Assignee:

Immunex Corporation - Seattle WA
International Classification:

A61K 39395
US Classification:

4241451, 435325, 435326, 5303871, 5303899, 5303881, 53038823, 53038824, 5303891, 5303892
Abstract:

A novel cytokine designated TRAIL induces apoptosis of certain target cells, including cancer cells and virally infected cells. Isolated DNA sequences encoding TRAIL are disclosed, along with expression vectors and transformed host cells useful in producing TRAIL polypeptides. Antibodies that specifically bind TRAIL are provided as well.

Tweak Receptor
view source
US Patent:

6727225, Apr 27, 2004
Filed:

Jun 18, 2001
Appl. No.:

09/883777
Inventors:

Steven R. Wiley - Seattle WA
Assignee:

Immunex Corporation - Seattle WA
International Classification:

A61K 3800
US Classification:

514 12, 514 2, 530300, 530350
Abstract:

The present invention provides the TWEAK receptor and methods for identifying and using agonists and antagonists of the TWEAK receptor. In particular, the invention provides methods of screening for agonists and antagonists and for treating diseases or conditions mediated by angiogenesis, such as solid tumors and vascular deficiencies of cardiac or peripheral tissue.

Tweak Receptor
view source
US Patent:

6824773, Nov 30, 2004
Filed:

Dec 19, 2000
Appl. No.:

09/742454
Inventors:

Steven R. Wiley - Seattle WA
Assignee:

Immunex Corporation - Seattle WA
International Classification:

A61K 39395
US Classification:

4241301, 4241391, 4241431, 514 2
Abstract:

The present invention provides the TWEAK receptor and methods for identifying and using agonists and antagonists of the TWEAK receptor. In particular, the invention provides methods of screening for agonists and antagonists and for treating diseases or conditions mediated by angiogenesis, such as solid tumors and vascular deficiencies of cardiac or peripheral tissue.

Human Serpin Polypeptides
view source
US Patent:

6958387, Oct 25, 2005
Filed:

Mar 8, 2002
Appl. No.:

10/094944
Inventors:

Howard R. G. Clarke - Seattle WA, US
Robert F. DuBose - Bellevue WA, US
Steven R. Wiley - Seattle WA, US
Assignee:

Immunex Corporation - Seattle WA
International Classification:

C07K001/00
C12P021/06
C12N015/09
C12N001/20
C07H021/04
US Classification:

530350, 435 692, 435 691, 4353201, 4352523, 4352542, 435325, 536 232
Abstract:

This invention relates to Thypin, a new member of the human serpin polypeptide family, methods of making Thypin polypeptides and using these polypeptides to treat various medical disorders and to methods of screening for compounds that agonize or antagonize Thypin polypeptide activities.

Human Serpin Polypeptides
view source
US Patent:

7132264, Nov 7, 2006
Filed:

Sep 2, 2005
Appl. No.:

11/219282
Inventors:

Howard R. G. Clarke - Seattle WA, US
Robert F. DuBose - Bellevue WA, US
Steven R. Wiley - Seattle WA, US
Assignee:

Immunex Corporation - Thousand Oaks CA
International Classification:

C07K 1/00
C07H 21/02
C07H 21/04
C12N 1/20
C12N 5/00
US Classification:

435 692, 536 231, 536 235, 4352523, 435325, 4353201, 530350
Abstract:

This invention relates to Thypin, a new member of the human serpin polypeptide family, methods of making Thypin polypeptides and using these polypeptides to treat various medical disorders and to methods of screening for compounds that agonize or antagonize Thypin polypeptide activities.

Claudin Polypeptides
view source
US Patent:

7186802, Mar 6, 2007
Filed:

Aug 15, 2001
Appl. No.:

10/344487
Inventors:

Adel Youakim - Seattle WA, US
Robert F. DuBose - Bellevue WA, US
Steven R. Wiley - Seattle WA, US
Assignee:

Immunex Corporation - Thousand Oaks CA
International Classification:

C07K 1/00
G01N 33/53
A61K 38/00
US Classification:

530350, 435 71, 514 12
Abstract:

This invention relates to new members of the human Claudin polypeptide family, to methods of making such polypeptides, and to methods of using them to treat Claudin-associated conditions and to identify compounds that alter Claudin polypeptide activities.

Compositions And Methods Relating To Multimeric And Oligomeric Soluble Fragments Of The Tweak Receptor
view source
US Patent:

7482430, Jan 27, 2009
Filed:

Jul 23, 2004
Appl. No.:

10/898575
Inventors:

Steven R. Wiley - Seattle WA, US
Assignee:

Amgen Inc. - Thousand Oaks CA
International Classification:

A61J 38/00
A61K 39/00
C07K 14/00
US Classification:

530350, 530300, 4241921, 514 2, 514 12
Abstract:

The present invention provides methods and compositions relating to fusion proteins comprising multimeric soluble TWEAK receptor fragments and an oligomerization domain. Such fusion proteins are useful for antagonizing the TWEAK receptor and for treating diseases or conditions mediated by angiogenesis, such as solid tumors and inflammatory conditions.

Tweak Receptor
view source
US Patent:

7495086, Feb 24, 2009
Filed:

Oct 22, 2004
Appl. No.:

10/971250
Inventors:

Kristine M. Kim - Mill Creek WA, US
Steven R. Wiley - Seattle WA, US
Randal R. Ketchem - Snohomish WA, US
Assignee:

Immunex Corporation - Thousand Oaks CA
International Classification:

C07K 16/00
US Classification:

5303881, 5303913
Abstract:

The present invention provides the TWEAK receptor and methods for identifying and using agonists and antagonists of the TWEAK receptor. In particular, the invention provides methods of screening for agonists and antagonists and for treating diseases or conditions mediated by angiogenesis, such as solid tumors and vascular deficiencies of cardiac or peripheral tissue.

Name / Title

Company / Classification

Phones & Addresses

Steven Wiley
Owner

Imdaptive Inc.
Commercial Physical and Biological Research

3010 Nw 56Th St, Seattle, WA 98107

Steven Wiley
Owner

Imdaptive Inc.

3010 NW 56 St, Seattle, WA 98107
(206)7349738

Steven Wiley
Director

DRYER SOLUTIONS INC

17350 State Hwy 249 STE 220, Houston, TX 77064

Steven Wiley

Find Legal Paternity Test
Infectious Disease Doctor

450 S Kitsap Blvd STE 202, Port Orchard, WA 98366
(888)5228386

Steven L. Wiley

WILEY & COLEMAN PROPERTIES, LTD

Steven M. Wiley
Principal

Uvs Enterprises
Management Consulting Services

4660 Beechnut St, Houston, TX 77096
5450 Carew St, Houston, TX 77096
(713)6609202

Steven Wiley
Principal

Bowlite Archery Products
Ret Sporting Goods/Bicycles

11074 Regency Grn Dr, Cypress, TX 77429
34502 Wright Rd, Pinehurst, TX 77362

Steven M. Wiley
Director, Manager

UVS ENTERPRISES, LLC

5450 Crane St, Houston, TX 77026
1001 W Loop S, Houston, TX 77027
5450 Carew St, Houston, TX 77096

Isbn (Books And Publications)

The Human Side Of High Performance: Empowering Yourself For The Future

view source

Author
Steven B. Wiley

ISBN #
0787245313

The Human Side Of High Performance: Empowering Yourself For The Future

view source

Author
Steven B. Wiley

ISBN #
0787265195

Rainmakers, Closers, and Other Sales Myths

view source

Author
Steven Wiley

ISBN #
0761835482

Lawyers & Attorneys

Steven Blythe Wiley - Lawyer

view source

Licenses:

Virginia - Authorized to practice law 2001

Steven Wiley - Lawyer

view source

ISLN:

902762303

Admitted:

1989

University:

University of Nebraska at Lincoln, B.S., 1978; University of Nebraska at Lincoln, M.B.A., 1980

Law School:

University of Nebraska at Lincoln, J.D., 1988

Steven Wiley - Lawyer

view source

Office:

Wiley Law Offices, PLLC

Specialties:

Litigation
Personal Injury
Real Estate
Defective and Dangerous Products
Appeals
General Practice

ISLN:

916832733

Admitted:

2001

University:

Concord College, B.A., 1998

Law School:

Washington & Lee University School of Law, J.D., 2001

Resumes

Founder And President

view source

Location:

Seattle, WA

Industry:

Biotechnology

Work:

Imdaptive since Oct 2008
Founder and President
VLST Mar 2004 - Sep 2008
Founder and CTO
Amgen 2003 - 2004
Scientist
Immunex 1993 - 2003
Senior Scientist
Abbott Laboratories 1996 - 1998
Scientist

Education:

University of Wisconsin-Madison 1987 - 1993
PhD., Cellular and Molecular biology University of Chicago 1982 - 1986
B.S., Mathmatics

Skills:

Molecular Biology
Protein Chemistry
Biopharmaceuticals
Drug Discovery
Bioinformatics
Biotechnology
Immunology
Technology Transfer
Lifesciences
Research
Protein Purification
Assay Development

Physician

view source

Work:

Community:

David Kahn, Gianni Xeros, Casey Mock, Keisha Freeman, Travis Vandehey, Esther Mpyisi, Vincent Akinola, Ronald Johnson, Shannon Otoski, Bill Lonergan, Ricky Pace

Steven Wiley (Vega)

view source

Schools:

John T. Reid Middle School Pittsfield MA 1995-1997

Community:

Joshua Brookman, Janet Danylieko, Shannon Mcmahon, Jessica Durso, Lauren Keeler, Ryan Pires, Sara Manning, Tonda Gunn, Karen Shaw, Phillip Smith, Roger Dowdell